Blass J P, Kark R A, Menon N K
N Engl J Med. 1976 Jul 8;295(2):62-7. doi: 10.1056/NEJM197607082950202.
Since patients with Friedreich's ataxia appear to oxidize pyruvate slowly, we measured the activity of the pyruvate dehydrogenase complex in disrupted fibroblasts from four patients with this syndrome and one patient with a clinical variant. The activity was 43 +/- 4 per cent of that in 16 controls (mean +/- S.E.M., P less than 0.001). The activity of the 2-oxoglutarate dehydrogenase complex was also lower in the patients' cells than in those of controls (50 +/- 2 per cent, P less than 0.001). However, the activity of cytochrome-c oxidase was normal (126 +/- 43 per cent of controls). Mixing experiments gave no evidence of soluble enzyme inhibitors or activators, and the addition of excess substrate or cofactor did not ameliorate the deficiencies. White blood cells from one of the patients had low activities of both complexes. Mutations of these dehydrogenase complexes occur in some patients with Friedreich's ataxia and lead to abnormally low activity of an enzyme of the tricarboxylic acid cycle.
由于弗里德赖希共济失调患者似乎丙酮酸氧化缓慢,我们测定了4例该综合征患者和1例临床变异患者的成纤维细胞匀浆中丙酮酸脱氢酶复合体的活性。该活性为16例对照者的43±4%(平均值±标准误,P<0.001)。患者细胞中2-氧代戊二酸脱氢酶复合体的活性也低于对照者(50±2%,P<0.001)。然而,细胞色素c氧化酶的活性正常(为对照者的126±43%)。混合实验未发现可溶性酶抑制剂或激活剂的证据,添加过量底物或辅因子也不能改善这些缺陷。其中1例患者的白细胞中这两种复合体的活性均较低。这些脱氢酶复合体的突变发生在一些弗里德赖希共济失调患者中,导致三羧酸循环中一种酶的活性异常降低。